These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Atypical presentations of spinal muscular atrophy type III (Kugelberg-Welander disease). Kang PB, Krishnamoorthy KS, Jones RM, Shapiro FD, Darras BT. Neuromuscul Disord; 2006 Aug; 16(8):492-4. PubMed ID: 16797181 [Abstract] [Full Text] [Related]
7. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy. Nelson L, Owens H, Hynan LS, Iannaccone ST, AmSMART Group. Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361 [Abstract] [Full Text] [Related]
11. Clinical and genetic study of spinal muscular atrophies in Oman. Koul R, Al Futaisi A, Chacko A, Rao V, Simsek M, Muralitharan S, Ganguly SS, Bayoumi R. J Child Neurol; 2007 Oct; 22(10):1227-30. PubMed ID: 17940251 [Abstract] [Full Text] [Related]
12. Proximal and distal motor nerve conduction velocities in Werdnig-Hoffmann disease. Imai T, Minami R, Nagaoka M, Ishikawa Y, Kameda K, Okabe M, Matsumoto H. Pediatr Neurol; 1990 Oct; 6(2):82-6. PubMed ID: 2340034 [Abstract] [Full Text] [Related]
14. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy. Febrer A, Rodriguez N, Alias L, Tizzano E. J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217 [Abstract] [Full Text] [Related]
15. Preservation of motor evoked potentials under anesthesia in children with spinal muscular atrophy type II undergoing spinal deformity surgery. Norton JA, Roy FD, Mahood JK. J Clin Neurophysiol; 2013 Aug; 30(4):382-5. PubMed ID: 23912577 [Abstract] [Full Text] [Related]